Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
If you lose a seed phrase, follow proven recovery steps and establish safeguards to regain access while preventing further risk.
20,981 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
CrossCountry Mortgage appoints Raena Pinchuk as sales manager for Coeur d’Alene and the broader Pacific Northwest, ai...
Analysts debate Cardano's valuation as ADA weakens and on-chain metrics lag, challenging bulls and funds alike. The d...
Solana is testing the Alpenglow upgrade with validator trials and a potential Q3 mainnet. Analysts weigh timing, risk...
A token real estate transfer to a child can trigger a massive capital gains bill. Here’s how suze orman’s warning par...
In May 2026, data show Ethereum as the leading real-world settlement layer amid a growing tokenized-asset market. Inv...
A fresh retirement-income blueprint uses a $1 million portfolio anchored by SCHD to target roughly $58,000 per year i...
Lemonade has chased rapid growth, but the real investment signal is in its loss ratio. This article explains why lemo...
A retired couple aims to fund $14,500 in monthly expenses from a $2.5 million portfolio. The plan combines three inco...
Debt-averse guidance from Dave Ramsey remains influential, but current borrowing costs and investment opportunities a...
Top AI chiefs urged Congress to curb risks as AI tech makes it easier to design dangerous biological materials. The l...
As rates shift in 2026, a tax-savvy strategy centers on a $750,000 municipal bond sleeve designed to generate steady,...